TMDX TransMedics Group, Inc.
Nasdaq · SEC CIK 1756262 · EDGAR
- Bought, last 12 months
- $1.11M 2 purchases by 2 insiders
- Sold, last 12 months
- $4.87M 10 sales by 7 insiders
- Filings on record
- 240 since 2021-07-06, latest 2026-09-14 16:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Weill David | Dir | $109.1K | $1.22M |
| Hernandez Gerardo | CFO | — | $1.25M |
| Hassanein Waleed H | Pres, CEO, Dir | $1.00M | — |
| Gunderson Thomas J. | Dir | — | $722.4K |
| Ranganath Anil P. | See remarks | — | $555.9K |
| Basile Edward M | Dir | — | $540.3K |
| Corcoran Nicholas | See remarks | — | $412.6K |
| Lovell Stephanie | Dir | — | $178.5K |
| Forsyth Matthew S. | See Remarks | — | — |
| Cecere Giovanni | Chief Commercial Off | — | — |
Transactions 350
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-22 | 2022-07-20 | TMDX | Carey John F | VP of Ops | M - OptEx | $13.99 | +1,500 | 754 | New | +$21.0K |
| D | 2022-07-12 | 2022-07-11 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $32.98 | -1,500 | 379 | -80% | -$49.5K |
| D | 2022-07-12 | 2022-07-11 | TMDX | Carey John F | VP of Ops | M - OptEx | $16.14 | +1,500 | 1,879 | +396% | +$24.2K |
| D | 2022-07-06 | 2022-07-05 | TMDX | Gordon Stephen | CFO | S - Sale+OE | $35.00 | -10.0K | 5,714 | -64% | -$350.0K |
| D | 2022-07-06 | 2022-07-05 | TMDX | Gordon Stephen | CFO | M - OptEx | $2.21 | +10.0K | 15.7K | +175% | +$22.1K |
| I | 2022-07-06 | 2022-07-05 | TMDX | TOBIN JAMES R | Dir | S - Sale | $35.00 | -48.5K | 302.1K | -14% | -$1.70M |
| D | 2022-07-06 | 2022-07-05 | TMDX | Khayal Tamer I | Chief Commercial Off | S - Sale+OE | $35.06 | -13.5K | 46.1K | -23% | -$473.5K |
| D | 2022-07-06 | 2022-07-05 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $0.28 | +13.5K | 59.6K | +29% | +$3,781 |
| D | 2022-06-29 | 2022-06-28 | TMDX | Carey John F | VP of Ops | M - OptEx | $0.28 | +2,724 | 3,103 | +719% | +$762.72 |
| D | 2022-06-29 | 2022-06-28 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $32.87 | -2,724 | 379 | -88% | -$89.5K |
| DM | 2022-06-27 | 2022-06-24+ | TMDX | Carey John F | VP of Ops | S - Sale+OE | $32.58 | -6,276 | 379 | -94% | -$204.5K |
| DM | 2022-06-27 | 2022-06-24+ | TMDX | Carey John F | VP of Ops | M - OptEx | $0.28 | +6,276 | 3,335 | New | +$1,757 |
| D | 2022-06-03 | 2022-06-01 | TMDX | Carey John F | VP of Ops | M - OptEx | $0.28 | +1,500 | 1,879 | +396% | +$420.00 |
| DM | 2022-06-03 | 2022-06-01 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $28.19 | -1,500 | 901 | -62% | -$42.3K |
| I | 2022-05-06 | 2022-05-04 | TMDX | TOBIN JAMES R | Dir | S - Sale | $29.94 | -48.5K | 350.6K | -12% | -$1.45M |
| D | 2022-05-06 | 2022-05-04 | TMDX | Carey John F | VP of Ops | M - OptEx | $0.28 | +1,500 | 1,879 | +396% | +$420.00 |
| D | 2022-05-06 | 2022-05-04 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $25.31 | -1,500 | 379 | -80% | -$38.0K |
| D | 2022-04-04 | 2022-04-01 | TMDX | Carey John F | VP of Ops | M - OptEx | $0.28 | +1,500 | 1,879 | +396% | +$420.00 |
| D | 2022-04-04 | 2022-04-01 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $26.85 | -1,500 | 379 | -80% | -$40.3K |
| DM | 2022-03-30 | 2022-03-28 | TMDX | Carey John F | VP of Ops | M - OptEx | $10.85 | +4,500 | 3,912 | New | +$48.8K |
| D | 2022-03-30 | 2022-03-28 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $25.01 | -4,500 | 379 | -92% | -$112.5K |
| D | 2022-01-07 | 2022-01-06 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | M - OptEx | $0.28 | +122.4K | 526.2K | +30% | +$34.3K |
| D | 2021-12-28 | 2021-12-23 | TMDX | Provost Miriam | VP of US Regulatory, FDA Rel | M - OptEx | $3.22 | +884 | 9,438 | +10% | +$2,846 |
| I | 2021-12-16 | 2021-12-15 | TMDX | TOBIN JAMES R | Dir | G - Gift | $0.00 | -25.5K | 399.1K | -6% | $0 |
| M | 2021-11-30 | 2021-11-29 | TMDX | KANIA EDWIN M JR | Dir | P - Purchase | $22.56 | +100.0K | 302.9K | +49% | +$2.26M |
| 2021-11-22 | 2021-11-19 | TMDX | KANIA EDWIN M JR | Dir | J - Other | $0.00 | +49.0K | 202.9K | +32% | $0 | |
| MI | 2021-11-22 | 2021-11-17+ | TMDX | KANIA EDWIN M JR | Dir | J - Other | $0.00 | -854.8K | 0 | -100% | $0 |
| I | 2021-11-22 | 2021-11-17 | TMDX | KANIA EDWIN M JR | Dir | G - Gift | $0.00 | -11.0K | 46.1K | -19% | $0 |
| D | 2021-11-02 | 2021-11-01 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $28.16 | -1,680 | 0 | -100% | -$47.3K |
| D | 2021-11-02 | 2021-11-01 | TMDX | Carey John F | VP of Ops | M - OptEx | $2.21 | +1,680 | 1,680 | New | +$3,713 |
| DM | 2021-10-05 | 2021-10-01 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $32.33 | -1,680 | 0 | -100% | -$54.3K |
| D | 2021-10-05 | 2021-10-01 | TMDX | Carey John F | VP of Ops | M - OptEx | $2.21 | +1,680 | 1,680 | New | +$3,713 |
| D | 2021-09-17 | 2021-09-15 | TMDX | Provost Miriam | VP of US Regulatory, FDA Rel | M - OptEx | $16.14 | +5,625 | 12.4K | +83% | +$90.8K |
| D | 2021-09-17 | 2021-09-15 | TMDX | Provost Miriam | VP of US Regulatory, FDA Rel | S - Sale+OE | $31.34 | -3,877 | 8,554 | -31% | -$121.5K |
| D | 2021-09-09 | 2021-09-07 | TMDX | Gordon Stephen | CFO | M - OptEx | $0.67 | +10.0K | 15.7K | +175% | +$6,700 |
| D | 2021-09-09 | 2021-09-07 | TMDX | Gordon Stephen | CFO | S - Sale+OE | $35.00 | -10.0K | 5,714 | -64% | -$350.0K |
| D | 2021-09-09 | 2021-09-07 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $0.28 | +3,941 | 50.0K | +9% | +$1,103 |
| D | 2021-09-09 | 2021-09-07 | TMDX | Khayal Tamer I | Chief Commercial Off | S - Sale+OE | $35.08 | -3,941 | 46.1K | -8% | -$138.3K |
| D | 2021-09-03 | 2021-09-01 | TMDX | Carey John F | VP of Ops | M - OptEx | $2.21 | +1,680 | 1,680 | New | +$3,713 |
| DM | 2021-09-03 | 2021-09-01 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $31.98 | -1,680 | 600 | -74% | -$53.7K |
| D | 2021-09-01 | 2021-08-30 | TMDX | Sullivan John F | VP of Quality, Engineering | M - OptEx | $0.28 | +3,200 | 14.3K | +29% | +$896.00 |
| D | 2021-08-04 | 2021-08-02 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $28.33 | -1,680 | 0 | -100% | -$47.6K |
| D | 2021-08-04 | 2021-08-02 | TMDX | Carey John F | VP of Ops | M - OptEx | $2.21 | +1,680 | 1,680 | New | +$3,713 |
| D | 2021-08-03 | 2021-07-30 | TMDX | Provost Miriam | VP of US Regulatory, FDA Rel | M - OptEx | $3.22 | +2,206 | 6,806 | +48% | +$7,103 |
| D | 2021-07-19 | 2021-07-15 | TMDX | Khayal Tamer I | Chief Commercial Off | S - Sale+OE | $35.10 | -5,152 | 46.1K | -10% | -$180.8K |
| D | 2021-07-19 | 2021-07-15 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $0.28 | +5,152 | 51.2K | +11% | +$1,443 |
| D | 2021-07-16 | 2021-07-15 | TMDX | Gordon Stephen | CFO | M - OptEx | $0.67 | +10.0K | 15.7K | +175% | +$6,700 |
| D | 2021-07-16 | 2021-07-15 | TMDX | Gordon Stephen | CFO | S - Sale+OE | $35.00 | -10.0K | 5,714 | -64% | -$350.0K |
| D | 2021-07-06 | 2021-07-01 | TMDX | Carey John F | VP of Ops | M - OptEx | $2.21 | +1,680 | 1,680 | New | +$3,713 |
| DM | 2021-07-06 | 2021-07-01 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $33.65 | -1,680 | 0 | -100% | -$56.5K |
Purchase Sale Sale after option exercise All abbreviations